Lifeway Foods, Inc. — 2020 Form 10-K
Reporting period: Fiscal year ended December 31, 2020. This is an annual report, not a standalone fourth-quarter filing; the supplied text does not provide separate Q4 results. Unless noted, financial figures are in millions of dollars.
Business context
Lifeway produces and markets cultured dairy products, led by drinkable kefir. It reported one operating segment and generated approximately 99% of revenue from products made at its own facilities. Drinkable kefir other than ProBugs contributed $81.4 million, or 80% of 2020 sales. The business is concentrated in the U.S.; two customers together accounted for approximately 21% of annual sales.
Financial performance and liquidity
| Metric | 2020 | 2019 |
|---|---|---|
| Net sales | $102.0 | $93.7 |
| Gross profit / margin | $26.9 / 26.4% | $22.1 / 23.6% |
| Operating income (loss) / margin | $4.9 / 4.8% | ($1.9) / (2.1%) |
| Net income | $3.2 | $0.5 |
| Basic and diluted EPS | $0.21 | $0.03 |
| Cash from operating activities | $6.4 | $3.8 |
| Capital expenditures | $1.9 | $1.2 |
| Cash and cash equivalents at year-end | $7.9 | $3.8 |
Revenue increased 8.9%, primarily from higher branded drinkable kefir volumes. Gross margin improved mainly because of favorable milk pricing and, to a lesser extent, freight costs. Operating expenses fell 8.6% to $22.0 million; selling expense declined with reduced marketing events and demonstrations, while G&A declined mainly due to lower compensation and incentive expense.
Net income rose to $3.2 million from $0.5 million. Comparability is affected by 2019 investment-related gains: that year included a $1.7 million fair-value gain and $1.4 million realized gain on investments, while 2020 had no fair-value gain and only $4,000 of realized gain. Income tax expense was $1.6 million in 2020 versus $0.8 million in 2019; the effective tax rate was 33.1% versus 63.3%.
Current assets were $24.1 million and current liabilities $8.4 million at year-end. The revolving credit facility had $2.768 million outstanding, with $2.223 million available to borrow. The facility limit was $5 million, matures June 30, 2025, and carried a 2.10% interest rate at year-end. Lifeway reported compliance with its debt covenants. Net cash increased $4.1 million in 2020. Investing activities used $1.9 million, primarily reflecting $1.9 million of capital spending; financing activities used $0.4 million, including share repurchases.
Material changes and unusual items
- Sales mix shifted further toward drinkable kefir: its share excluding ProBugs increased to 80% from 77%. Cheese sales rose to $12.9 million from $11.5 million; cream and other sales fell to $2.9 million from $4.2 million, partly reflecting lower butterfat prices.
- The September 2020 credit amendment reduced the revolving line limit to $5 million, added a quarterly minimum working-capital covenant of $11.25 million, removed monthly borrowing-base reporting, and extended the facility to June 2025. A fixed-charge coverage covenant of at least 1.25:1.00 remains.
- The company repurchased 179,000 shares for $405,000 in 2020 and reached the amended plan’s 625,000-share threshold; no shares remained available under that authorization at year-end.
- The company paid its board chair $1.0 million for consulting services in 2020 and $0.6 million in product royalties. A December 2020 amended agreement set an annual service fee of $0.5 million and a target performance fee of $0.5 million, subject to performance criteria.
Outlook, risks, and contingencies
No quantified revenue or earnings guidance is provided. Management said COVID-19 had driven increased demand from pantry loading and greater at-home consumption, and that facilities were operating with available capacity and no material supply-chain constraints at the time of filing. Management cautioned that demand could recede as restrictions ease and that pandemic duration, future waves, supply availability and costs, and consumer behavior make the eventual financial impact uncertain. It stated that foreseeable liquidity needs were expected to be met through operating cash flow, cash, and the revolving facility.
Key risks include competition and retailer pricing pressure; dependence on major customers and distributors; milk and other input-cost volatility; supply-chain or facility disruptions, including cybersecurity and labor risks; food safety, recall, regulatory and certification risks; and debt covenant and financing constraints. Lifeway disclosed ordinary-course legal matters, but said no accrued matters were material and that resolution was not expected to have a material adverse effect; it could not estimate a possible loss range. The auditor issued an unmodified opinion and reported no critical audit matters. Management reported effective disclosure controls and internal control over financial reporting.
Important facts for investors to verify
- Whether elevated pandemic-era demand persisted or normalized after 2020, and how much sales growth came from volume versus other factors.
- Whether margin gains from favorable milk and freight costs were sustainable, given commodity and input-cost exposure.
- Customer concentration, particularly the identity and ongoing contribution of the two customers representing approximately 21% of sales.
- Compliance with the $11.25 million minimum working-capital covenant and 1.25:1.00 fixed-charge coverage covenant, plus the availability and terms of borrowing under the facility.
- The assumptions supporting goodwill and brand-name valuations, and the effect of related-party consulting and royalty arrangements on expenses and governance.